Mira Pharmaceuticals (MIRA) Assets (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Assets of $11.1 million for Q4 2025, up 45.33% sequentially from $7.6 million in Q3 2025, and up 279.52% YoY from $2.9 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Assets (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals has reported Assets for 4 years, with the latest figure at $11.1 million in Q4 2025.
- Quarterly Assets rose 279.52% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 million (up 279.52% YoY) and the FY2025 annual result came in at $11.1 million, up 279.52% from the prior year.
- Assets advanced to $11.1 million in Q4 2025 per MIRA's latest filing, from $7.6 million in the prior quarter.
- Over five years, Assets peaked at $11.1 million in Q4 2025 and troughed at $858074.0 in Q4 2022.
- A 4-year average of $4.6 million and a median of $3.8 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2025: Assets surged 474.83% in 2023, then slumped 63.23% in 2025.
- Over 4 years, Assets stood at $858074.0 in 2022, then soared by 474.83% to $4.9 million in 2023, then slumped by 40.74% to $2.9 million in 2024, then jumped by 279.52% to $11.1 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $11.1 million, $7.6 million, and $868318.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 82.83 Bn |
| 10 | Mira Pharmaceuticals | 18.47 Mn | 7.44 Mn | - | 11.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.09 Mn |
| Sep 30, 2025 | 7.63 Mn |
| Jun 30, 2025 | 868,318.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Mar 31, 2024 | 3.81 Mn |
| Dec 31, 2023 | 4.93 Mn |
| Sep 30, 2023 | 9.02 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Dec 31, 2022 | 858,074.00 |